Wugen
Business Services · Missouri, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
4260 Forest Park Ave Ste 100, Saint Loui...Phone Number
(636) 385-5306Website
www.wugen.comRevenue
$16.3 MillionIndustry
About Wugen
Founded in 2018, Wugen Inc., is a biotechnology company developing a novel CAR-T therapy platform including an "off-the-shelf" fratricide-resistant CAR-T cell therapy for T-cell malignancies. Wugen's state-of-the-art gene editing technologies and cutting-edge CAR-T cell therapy address some of the challenges that have limited the clinical development of allogeneic CAR-T cells. Wugen was founded based on technology licensed from Washington University in St. Louis.Explore more
Wugen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Wugen
Compare insights from companies similar to Wugen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Wugen Tech Stack
A closer look at the technologies used by Wugen
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Wugen
Sign Up For FreeTo access detailed company insights
Founded in 2018, Wugen Inc., is a biotechnology company developing a novel CAR-T therapy platform including an "off-the-shelf" fratricide-resistant CAR-T cell therapy for T-cell malignancies. Wugen's state-of-the-art gene editing technologies and cutting-edge CAR-T cell therapy address some of the challenges that have limited the clinical developme... Read More
